Galectin Therapeutics shares owned by Vanguard Portfolio Management
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Vanguard Portfolio Management
from 13F filings
Historical chart of Vanguard Portfolio Management investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Vanguard Portfolio Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Vanguard Portfolio Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $1.5M | 328k | 4.64 |